Americas
Americas Pharmaceuticals & Healthcare Insight provides country-by-country analysis of the key trends impacting the prescription, OTC and generic drugs industries across the Americas. Americas Pharmaceuticals & Healthcare Insight includes competitive intelligence on the growth strategies of leading national and multinational companies, along with 5-year industry forecasts for each country. The service includes access to the very latest analysis, a searchable archive of articles and data and the ability to download PDFs of current and back issues.
›› To gain FREE online access for 14 days and to download a FREE PDF, click trial.
›› To receive 15 monthly pdf issues for the price of 12 and to gain immediate online access, click subscribe.
Ecuador / Industry
BMI View: The steadily growing Ecuadorian pharmaceutical market will provide revenue-earning opportunities for Takeda. However, the limited market size and low per capita spending on pharmaceutical products, as well as the country's unorthodox drug regulation policies, may restrict foreign drugmakers' growth opportunities.
2013-03-22Industry
BMI View: Despite the undoubted clinical and commercial success of traditional chemotherapy, demand for new targeted cancer therapies is likely to remain high. This will provide continued...
2013-03-22United States / Industry
BMI View: The outcome of the recent compulsory licence application to manufacture a generic version of Bristol-Myers Squibb (BMS)'s Sprycel (dasatinib) will likely favour the Indian...
2013-03-19Industry Developments
Ecuador
BMI View: The steadily growing Ecuadorian pharmaceutical market will provide revenue-earning opportunities for Takeda. However, the limited market size and low per capita spending on...
2013-03-22BMI View: Despite the undoubted clinical and commercial success of traditional chemotherapy, demand for new targeted cancer therapies is likely to remain high. This will provide continued...
2013-03-22United States
BMI View: The outcome of the recent compulsory licence application to manufacture a generic version of Bristol-Myers Squibb (BMS)'s Sprycel (dasatinib) will likely favour the Indian...
2013-03-19BMI View: Bayer's strong presence in Latin America has helped the company deliver above expectation sales in 2012. However, the company did not outperform the general market in the...
2013-03-19
